While SIGLEC7 has been recognized as the primary GD2 receptor in humans, the lack of a murine homolog introduces uncertainty regarding the extent to which osteosarcoma xenograft models accurately reflect human disease pathology. Here, SIGLEC7 is linked to osteosarcoma.